NCT02788552View on ClinicalTrials.gov

Optimum Thiamine Intervention (OpTIn) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 30, 2019

Study Completion Date

August 1, 2019

Conditions
Wernicke-Korsakoff Syndrome
Interventions
DRUG

Thiamine Hydrochloride

Administered Intravenously in 100ml bag of normal saline (0.9%) infused over 30 mins.

Trial Locations (1)

0810

Alice Springs Hospital, Alice Springs

All Listed Sponsors
lead

Menzies School of Health Research

OTHER

NCT02788552 - Optimum Thiamine Intervention (OpTIn) Trial | Biotech Hunter | Biotech Hunter